Objective: To assess physician prognosis and treatment recommendations for intracerebral hemorrhage (ICH) and to determine the effect of providing physicians a validated prognostic score.
Substantial heterogeneity has been identified in use of do-not-resuscitate orders and lifesustaining treatments after stroke. [1] [2] [3] [4] There are many potential sources of this observed variability in end-of-life treatment at the patient, physician, and health system level. 1, [5] [6] [7] The physician estimation and communication of the patient's prognosis for recovery is a critical first step to setting a treatment plan for patients with severe stroke such as intracerebral hemorrhage (ICH). [8] [9] [10] Many prognostic scores have been developed for ICH, 11, 12 though there has been almost no formal evaluation of the utility and effect of these prognostic scores on physician behavior or patient-level outcomes. 9, 13 To develop a better understanding of current physician practice patterns for ICH prognostication and treatment recommendations, we conducted a nationwide survey of neurologists and neurosurgeons regarding the management of ICH. The primary objectives of this study were to (1) identify the physician-and patient-level determinants of variability in prognostic estimates and treatment recommendations and (2) determine the effect of providing a prognostic score on physician recommendations for intensity of treatment.
METHODS Physician identification and survey distribution. Physicians were identified based on a simple random sample of actively practicing physicians with a specialty of neurology, vascular neurology, or neurosurgery from the American Medical Association Masterfile. Written versions of the survey were sent via US mail along with an introductory letter, $2 cash incentive, and a prepaid return envelope. Follow-up surveys (no incentive) were sent to nonresponders after approximately 8 weeks. Surveys were distributed on August 27, 2013, and October 23, 2013 . Completed surveys were collected and manually double-entered using REDCap electronic data capture tools hosted at the University of Michigan. 14 Case scenarios. Each survey included 2 case vignettes describing a patient presenting with ICH. Each vignette provided a clinical description of symptoms, examination findings, representative slices from a noncontrast CT scan, and an estimate of the total hemorrhage volume. Patient characteristics were randomized within physician including patient age (older vs middle age), race (African American vs Caucasian), and severity of neurologic deficits (severe vs moderate). One case was intended to be of moderate severity, describing a woman (age randomized to 83 or 63 years) on warfarin for atrial fibrillation who presented with right hemiparesis and aphasia, Glasgow Coma Scale (GCS) score of 11 (eye 3, verbal 2, motor 6), and a hemorrhage volume of 45 mL. The other case was more severe, describing a woman (age randomized to 76 or 56 years) who was found minimally responsive and intubated in the emergency department with a GCS of 7T (eye 2, verbal 1T, motor 4), and a hemorrhage volume of 120 mL with intraventricular extension.
In half of the surveys, the results from a validated prognostic score (FUNC score 12 ) were shown after each case ("One validated predictive model for ICH suggests that patients of similar severity have about a X% chance of returning to functional independence by 90 days," where X was 0%, 13%, or 66% depending on the age and GCS). Randomization of the prognostic score was performed such that each physician saw the prognostic score for both cases or for neither case to avoid contamination within a survey. This design resulted in a total of 16 versions of the survey. An overview of the randomization of vignettes is shown in figure 1, with full details of the randomization and full text from the case vignettes shown in appendix e-1 and table e-1 on the Neurology ® Web site at Neurology.org.
Outcome measures. After each case, the physicians estimated the patient's probability of 30-day mortality as well as 90-day return to functional independence (both free text write-in from 0% to 100%). Physicians were then told that the family was uncertain about the level of intensity of treatment to provide, and that the family specifically asked for the physician's recommendation for the initial intensity of treatment. Physicians then indicated their recommended initial intensity of treatment on a 6-point ordinal scale with anchors of 1 5 comfort measures and 6 5 full intensive treatment (see appendix e-1 for text of questions and response options).
Physician characteristics. After the cases, additional questions assessed physician demographics, practice setting, optimism, 15 religious salience, 16 religious attendance, religious affiliation, and empathy ("How do you think your patients would rate your level of empathy as compared to other physicians?" with response options of "I'm much less empathetic," "I'm a little less empathetic," "I'm about average," "I'm a little more empathetic," and "I'm much more empathetic").
Statistical analysis. Descriptive statistics were used to summarize the physician characteristics. Repeated measures regression models with robust standard errors were used for all outcomes (linear for mortality and functional independence; ordinal and logistic for treatment recommendations) to account for clustering of responses within physicians. Model covariates were prespecified. All patient characteristics (age, GCS, and race) as well as case order were included in all models. Interaction terms between patient-level variables and case order were explored and retained if significant at p , 0.10 to account for order effects. Physician variables included age (quartiles), sex, race/ethnicity (other vs non-Hispanic white), number of ICH cases seen in the prior 12 months (16 or more, none, reference 1-15), surgeon, academic practice, geographic region, empathy, optimism, and religious importance. The presence (vs absence) of the prognostic score was coded as a 5-item categorical variable (no prognosis provided 5 reference; each of the 4 possible combinations of age and GCS) since the effect of the prognostic score was found to be different for different cases (e.g., the effect of showing a 0% chance of recovery was different than showing a 13% or a 66% chance). This approach allowed the effect of the prognostic score to be evaluated both overall and on a per-case basis. An interaction term between age and severity was forced into all models so that prognostic score could be interpreted adjusting for the joint effects of age and severity.
For the analysis of physician treatment recommendations, the a priori plan was to treat this as a 6-item ordinal variable. An initial ordinal model was created adjusting only for patient factors to allow us to determine the effect of the prognostic score on the full ordinal scale. However, once physician factors were added to the model, the proportional hazards assumption was violated. Therefore, a second logistic model was created where responses were collapsed into 2 categories (responses of 1, 2, or 3 indicating treatment limitations vs 4, 5, or 6 indicating full treatment) and physician characteristics were added. Analyses were conducted with SAS software version 9.3 for Windows (SAS Institute, Cary, NC).
Standard protocol approvals, registrations, and patient consents. This study was approved by the Institutional Review
Board of the University of Michigan and determined to be exempt from ongoing review.
RESULTS
The survey was mailed to 4,000 randomly selected physicians. Completed surveys were received from 816, with 273 returned as undeliverable or ineligible, for a response rate of 816/3,727 (22%). Of the 816, another 74 had missing data on one or more key descriptive variables, leaving 742 available for full analysis. Cases excluded for missing data did not differ on responses for the study outcome measures. The characteristics of the study population are shown in table 1.
The distribution of predicted 30-day mortality by patient age and GCS is shown in figure 2, demonstrating a wide range of responses within each clinical scenario. The multivariable model for physician-predicted 30-day mortality is shown in table 2. Older (vs middle) patient age increased the mortality estimate by 7-10 percentage points, while the effect of higher severity (GCS 7T vs 11) ranged from 18 to 29 percentage points. Patient race had no effect on mortality predictions. Providing a prognostic score altered the physicians' predictions of mortality (p 5 0.001). This effect was seen primarily in the case of the 63-year-old patient with a GCS of 11, where the prognostic score (66% chance of independence) resulted in a 5-point decrease in the mortality estimate (p , 0.001).
Several physician factors were associated with mortality estimates (table 2) , with surgeons providing a lower mortality estimate by 10 percentage points than nonsurgeons. Number of ICH cases seen in the prior 12 months also had an effect, with physicians who saw 16 or more ICH cases tending to predict a higher mortality by 4 percentage points than those who saw 1 to 15 cases. Physicians in the Northeast and Southern regions of the United States predicted a higher chance of death than those in the Western United States. Overall, the within-physician correlation in responses was 0.26, suggesting that physician factors were responsible for 26% of the outcome variance. The final model R 2 was 0.32 (i.e., the model explained 32% of the variability in physician responses).
Results for the physician estimates of 90-day recovery are detailed in appendix e-2 and table e-2. Providing physicians with a prognostic score affected physician predictions (p , 0.001), with favorable prognostic score (66% predicted independence) associated with increased physician estimates of good outcome, while a poor prognostic score (0% predicted independence) decreased physician estimates of good outcome. The only physician-level variable associated with prediction of 90-day recovery was geographic region (p 5 0.02).
Results for the multivariable models investigating treatment recommendations are shown in table e-3, with the effect of the prognostic score shown in figure 3. When treatment recommendations were investigated as a 6-point ordinal variable, providing a prognostic score changed physicians' recommendations (p , 0.001). This effect varied depending on what probability of recovery was shown by the prognostic Figure 1 Randomization of case vignettes
Demonstration of the format of the different survey versions resulting from randomization of prognostic score, patient age, clinical severity, and race. Note that case order (whether the moderate or severe case was shown first) was also randomized, but this is not shown in the figure for clarity.
score. For the cases where the chance of recovery was shown to be 13%, the prognostic score had no effect on treatment recommendations. However, if the prognostic score suggested a 0% chance of functional recovery (76-year-old patient with GCS 7T), the likelihood of treatment limitations was increased (adjusted odds ratio [OR] 1.61, 95% confidence interval [CI] 1.12-2.33, p 5 0.01, adjusted for patient age, race, GCS, case order, age 3 GCS, and order 3 GCS). Conversely, if the score suggested a 66% chance of recovery (63-year-old patient with GCS 11), the likelihood of treatment limitations was decreased (adjusted OR 0.62, 95% CI 0.43-0.88, p 5 0.008, adjusted for same factors as above). Patient race was not associated with treatment recommendations in the ordinal model (adjusted OR 1.00, 95% CI 0.85-1.17, p 5 0.99). When treatment recommendations were collapsed into 2 categories (limited vs full treatment) to allow the exploration of physician characteristics, none of the investigated physician factors was associated with recommendations. Physicians recommended a lower treatment intensity (response of 1, 2, or 3 on the 6-point scale) in 32% of cases. The prognostic score remained associated with treatment recommendations, with a similar pattern of responses as the ordinal model (e.g., 66% chance of independence decreased treatment limitations, while a 0% chance showed a trend toward increased treatment limitations, see table e-3). African American patient race was not associated with physician recommendations for treatment limitations (adjusted OR 0.82, 95% CI 0.66-1.03, p 5 0.09) in the binary model, adjusted for patient and physician characteristics. DISCUSSION We identified substantial variability in physician prognostic estimates and treatment recommendations for cases of moderate to severe ICH. This variability existed despite providing sufficient clinical data to estimate chances of death or recovery based on commonly used ICH prognostic models. 12, 17 We also found that physician recommendations for initial treatment intensity were altered when they were provided with a validated prognostic score. If the prognostic score suggested a poor outcome (0% chance of 90-day independence), physicians were more likely to recommend treatment limitations compared with no prognostic score. If the prognostic score suggested a favorable outcome (66% chance of 90-day independence), physicians were less likely to recommend treatment limitations.
These findings have several implications. First, they suggest that prognostic information provided to a family about an ICH patient may vary depending on the particular physician involved in the case. Given the widespread variability seen in ICH endof-life treatment seen across institutions, 1 it is likely that differences in physician prognostication and recommendations play at least some role in unwanted variability in ICH treatment. Overly optimistic and overly pessimistic prognostic estimates can both have deleterious effects. Overly optimistic recommendations can lead to continuation of futile treatments and leave family members unprepared for death or poor outcome, while overly pessimistic predictions can lead to early treatment limitations and death in individuals who may have had a chance for recovery. Our results also suggest that increased use of validated prognostic scores may alter physician treatment recommendations in certain cases. While encouraging use of prognostic scores could be seen as a way to reduce unwanted variability in ICH treatment, there was still a wide range of treatment recommendations even when physicians were provided with a prognostic score. Furthermore, the prognostic score had no effect on treatment recommendations in the 2 cases with intermediate prognosis (13%) for functional recovery. Despite the wide availability of prognostic models for ICH, 12, 17 few are currently used in practice. Reasons for this are complex and likely due to multiple factors including lack of physician trust in models, difficulty in applying population average estimates to individual patients, and a belief that numbers may be misinterpreted by families. 18 Physicians tend to be reluctant to provide numeric prognostic estimates, and yet studies of surrogate decision-makers suggest that the majority of surrogates understand and accept the inherent uncertainty in these estimates and still want numeric estimates if they are available. 18, 19 Existing prognostic models for ICH may also be biased as they have been developed in cohorts with frequent decisions to limit life-sustaining treatments, which were in part based on prognostic variables incorporated into the scores. 20, 21 Since chart documentation of an ICH severity score is now an emerging quality metric for ICH and use of prognostic scores is likely to increase, 22 more formal study of the effect of these scores on patient outcomes seems warranted. 13 We identified relatively few physician characteristics associated with outcome predictions, and we found no factors predictive of physician treatment recommendations. The physician characteristic with the largest effect on mortality estimates was surgical specialty, with surgeons providing an estimate that was 10 percentage points lower (more favorable) than nonsurgeons. We did not have sufficient sample size to investigate possible effects of various subspecialties such as neurocritical care or vascular neurosurgery. Physician experience with ICH and geographic region were also associated with physician outcome predictions, though the effect sizes were relatively small (less than 5-6 percentage points for mortality estimates), and it is uncertain if these findings truly represent clinically meaningful differences. The majority of the variability in mortality estimates remained unexplained (model R 2 of 0.32) despite inclusion of physician demographics, practice characteristics, and personality traits. The lack of physician factors associated with responses suggests that targeting specific physician groups for additional training in neurologic prognostication is unlikely to be beneficial.
Physicians recommended a lower intensity of treatment (1, 2, or 3 on the 6-point ordinal scale) in approximately 1/3 of cases, despite national guidelines recommending against early treatment limitations in ICH. 23 This may be reflective of a general pattern of clinical nihilism that has been described in ICH. 2, 5 An American Heart Association Scientific Statement has suggested that physicians should be aware of their own potential biases when making recommendations and attempt to limit the effect of these biases on treatment recommendations. 9 Physicians may also make recommendations to limit life-sustaining treatment in an attempt to spare the patient from survival with disability 24, 25 and limit the surrogate's burden 26 of making such a difficult decision. This approach, however, may be problematic in situations where the prognosis is uncertain, or if the surrogate has not explicitly stated a desire to cede decision-making authority to the physician. 25 A study from a general ICU population showed that the majority of surrogates preferred to maintain the final decision-making authority for lifesustaining treatment, 27 suggesting that this paternalistic approach without first attempting to determine how involved the surrogate wants to be in decisions may be inappropriate. 25 We did not identify any consistent effect of patient race on physician treatment recommendations, which may seem in contrast to prior work suggesting racial and ethnic differences in use of life-sustaining treatments after ICH. 7,28 However, it is worth noting that in the current study, the patient's stated treatment preferences were held constant across race (see appendix e-1 for details of preference statement). Since the effect of race-ethnicity on lifesustaining treatments is likely explained in part by differences in patient or family preferences, it is not necessarily surprising that there were no racial differences observed in treatment recommendations. Alternatively, describing race in a text scenario (rather than with pictures or videos) may not have been a strong enough trigger for physicians to consider the effect of race on their responses. This work has limitations. It is possible that the survey scenarios and responses may not reflect the complexities of actual practice, and that physicians may be able to make better prognostic estimates and treatment recommendations when able to interact with the patient and family. However, given the infrequent use of advance directives and widespread misdiagnosis of patient preferences in other conditions, 9, 29 it is unlikely Table 2 Effect of prognostic score and patient and physician characteristics on physician-predicted mortality that our results are explained fully by the hypothetical nature of these scenarios. The study design does not allow us to determine if the prognostic score caused any individual physician to change his or her treatment recommendations, as the score was only randomized between physicians, and there was no withinphysician assessment of responses before and after viewing the score. Another limitation is the relatively low response rate (22%), which is a well-known problem in physician surveys. 30 However, the age, race/ethnicity, and proportion in academic practice is similar to that reported in a recent American Academy of Neurology member census. 31 Eighty-nine percent of respondents reported recent involvement in the care of ICH patients, suggesting that the results of this survey are representative of current clinical practice. We identified substantial variability in physician prognosis and treatment recommendations for ICH. Few physician factors were identified that predicted responses and much of the variability in responses remained unexplained. Increasing use of an accurate formal prognostic score may be one way to standardize physician prognostic estimates. Given the potential for a prognostic score to either increase or decrease the recommended intensity of treatment, careful study of the effect of these scores and how best to implement their use in clinical settings is warranted.
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